2017年

2017 LINC January 24-27, Leipzig, Germany

1. Tazaki J, Higami H, Nanto K, Iida O, Kimura T. Long term outcomes of coil embolization for Type II endoleak after EVAR.

KEYSTONE SYMPOSIA Epigenetics and Human Disease: Progress from Mechanisms to Therapeutics January 29-Feb 2, Seattle, WA, USA

1. Morita Y, Nishi E. Nardilysin-mediated epigenetic regulation contributes to the cell cycle progression and proliferation in mouse embryonic fibroblasts.

American College of Cardiology (ACC) 2017: 66th Annual Scientific Session & Expo March 17-19, Washington, D.C., USA

1. Yoshikawa Y, Shiomi H, Watanabe Hirotoshi, Natsuaki M, Kondo H, Tamura T, Morimoto T, Nakagawa Y, Kimura T. Application of DAPT Score to Predict Ischemic and Bleeding Events in Japanese Patients Undergoing Drug-eluting Stent Implantation: An Observation from a Pooled Cohort of the CREDO-Kyoto Cohort-2, RESET, and NEXT Trials.

KEYSTONE SYMPOSIA RNA-Based Approaches in Cardiovascular Disease March 27-30, USA

1. Nishino T, Horie T, Kuwabara Y, Nakao T, Nishiga M, Ide Y, Nakazeki F, Koyama S, Kimura M, Hanada R, Kimura T, Ono K: MicroRNA-33b promotes atherosclerotic plaque formation in Apoe-/- mice.
2. Nishiga M. MicroRNA-33 controls adaptive fibrotic response in the remodeling heart by preserving lipid raft cholesterol.

EuroPCR 2017 May 16-19, Paris, France

1. Toyota T, Morimoto T, Shiomi H, Yoshikawa H, Yaku H, Yamashita Y, Kimura T. Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic review and an up-dated meta-analysis.

ISSCR 15th Annual Meeting June 14-17, Boston, USA

1. Hatani T, Funakoshi S, Thomas J. Deerinck, Eric A. Bushong, Kimura T, Yamanaka S, Mark H. Ellisman, Hoshijima M, Yoshida Y. Stably Expressed APEX2 Identifies T-tubules and Dyad Formation in Engrafted iPSC-derived Cardiomyocytes in a Mouse Model of Myocardial Infarction.
2. Morimoto Y, Chonabayashi K, Kawabata H, Takaori-Kondo A, Yoshida Y, Modelling X-linked sideroblastic anemia with patient derived human induced pluripotent stem cells.
3. Okubo C, Nishikawa M, Takei I, Inagaki A, Narita M, Yamanaka S, Yoshida Y. Analysis of profile of HAND1 and HAND2 in early cardiogenesis using hiPSCs.

2nd International Symposium for Noncoding RNA Neo-taxonomy In conjunction with Tokyo RNA Club 23rd meeting June 26 , Tokyo, Japan

1. Ono K. Roles of microRNAs in cardiovascular diseases.

43rd Naito Conference Noncoding RNA：Biology, Chemistry, & Diseases June 27-30, SAPPORO, Japan

1. Ono K, Nishino T, Horie T, Kuwabara Y, Nakao T, Nishiga M, Ide Y, Nakazeki F, Koyama S, Kimura M, Kimura T. MicroRNA-33b promotes atherosclerotic plaque formation in Apoe-/- mice.
2. Horie T. Serum HDL Cholesterol decreases in microRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1).

CSI 2017 June 28 - July 01, frankfrut, Garmany

1. Imai M, Yoshida M, Toyota T, Shiomi H, Shizuta S, Saito N, Kimura T. Successful catheter treatment using pre-operative 3D organ model simulation for atrial septal defect with dextrocardia and interrupted inferior vena cava to the superior vena cava.

Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2017 July 10-13, Portland, USA

1. Yokoi F. l-cis-Diltiazem ameliorates impaired calcium channel inactivation in a patient-specific stem cell model of long-QT syndrome with a calmodulin mutation.

ESC Congress 2017 August 26-30, Barcelona, Spain

1. Kato T, Sasaki K, Funasako M, Miyamoto S, Izumi T, Haruna T, Yaku H, Kawase Y, Yamamoto E, Tamaki Y, Inuzuka Y, Inoko M, Ozasa N, Kimura T. Nutritional status in acute decompensated heart failure was closely linked to high in-hospital mortality (from the KCHF registry).
2. Nishiuchi S. Gene-based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers.
3. Watanabe Hirotoshi, Morimoto T, Shiomi H, Yoshikawa Y, Kato T, Saito N, Shizuta S, Yamaji K, Ando K, Kaji S, Furukawa Y, Akao M, Nakagawa Y, Kadota K, Kimura T. Postdischarge myocardial infarction after percutaneous coronary intervention: incidence, risk factors, size distribution.
4. Watanabe Hiroki, Ozasa N, Morimoto T, Shiomi H, Bao B, Kimura T. A Randomized Controlled Trial Evaluating the Efficacy of Long-term Use of Beta-blocker in Patients with ST-segment Elevation Myocardial Infarction treated with Primary Percutaneous Coronary Intervention.
5. Minamino E, Kato T, Morimoto T, Taniguchi T, Shiomi H, Nakatsuma K, Inoko M, Shirai S, Kitai T, Izumi C, Inada T, Ishii K, Saito N, Minatoya K, Kimura T. Causes of death in patients with severe aortic stenosis: a report from the CURRENT AS registry.
6. Yaku H, Kato M, Yokomatsu T, Yamamoto E, Tamaki Y, Inuzuka Y, Ozasa N, Morimoto T, Kato T, Kimura T. Age-related differences in characteristics and management of acute decompensated heart failure in Japan: insights from the Kyoto congestive heart failure registry.
7. Isehaq Al, Ashida N, Kimura T. Inhibition of NF-kappaB in Smooth Muscle Cells promotes calficication.
8. Yoshikawa Y, Shiomi H, Watanabe Hirotoshi, Natsuaki M, Kondo H, Tamura T, Morimoto T, Nakagawa Y, Kimura T. Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort and its prognostic significance.
9. Yoshikawa Y, Tamaki Y, Yaku H, Yamamoto E, Ozasa N, Inuzuka Y, Morimoto T, Inoko M, Nakagawa Y, Kato T, Kimura T. Use or nonuse of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients hospitalized for acute heart failure.
10. Ito S, Watanabe Hirotoshi, Morimoto T, Horiuchi H, Kimura T. Clinical Impact on Baseline Thrombocytopenia in Percutaneous Coronary Intervention.
11. Kozai C, Minami T, Nishikimi T, Nakagawa Y, Nakaob K, Kuwahara K, Koike K, Kimura T. Adipocyte-derived adrenomedullin suppresses age-and obesity-related increase in blood pressure.
12. Nishikimi T, Nakagawa Y, Kinoshita H, Moriuchi K, Inazumi H, Kuwahara K, Nakao K, Kimura T. O-linked oligosaccharaide attachment underestimates N-treminal proBNP-76(NTproBNP) levels in heart failure(HF) and chronic renal failure (CRF) on hemodialysis (HD).
13. Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, Sasaki K, Funasako M, InokoM. Evaluation of the relationship between atrial fibrillation and left ventricular geometric patterns.
14. Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, Sasaki K, Funasako M, InokoM. Characteristics of ECG in Patients with hypertrophic cardiomyopathy.
15. Seko Y, Kato T, Funasako M, Sasaki K, Nakane E, Miyamoto S, Izumi T, Haruna T, Inoko M. Characteristics of patients with small left ventricular diastolic dimension.
16. Shiba M, Kato T, Funasako M, Sasaki K, Nakane E, Miyamoto S, Izumi T, Haruna T, Ueyama K, Inoko M. Impact of psoriasis on myocardial infarction in a hospitalbased population in Japan.

The 61st Annual Scientific Meeting of The Korean Society of Cardiology October 12-14, Seoul, Korea

1. Horie T. MicroRNA in Atherosclerosis (JCS-KSC Joint Symposium (Basic Research)).

Transcatheter Cardiovascular Therapeutics Congress 2017 October 29-November 2, Denver, USA

1. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kitai T, Kawase Y, Izumi C, Kimura T. Sudden Cardiac Death in Patients with Severe Aortic Stenosis.

American Heart Association Scientific Sessions 2017 November 11-15, Anaheim, USA

1. Nishino T, Horie T, Kuwabara Y, Nakao T, Nishiga M, Ide Y, Nakazeki F, Koyama S, Kimura M, Kimura T, Ono K. MicroRNA-33b promotes atherosclerotic plaque formation in Apoe-/- mice.
2. Yoshida Y. IPS-Cell-Derived Cardiomyocyte Disease Modeling. (Frontiers in Science)
3. Toyota T, Morimoto T, Shiomi H, Yamaji K, Ando K, Ono K, Shizuta S, Saito N, Kato T, Kaji S, Furukawa Y, Kadota K, Horie M, Kimura T. Single-session Versus Staged Procedures for Elective Multi-vessel Percutaneous Coronary Intervention.
4. Hayano M. Human iPSC-Derived Myocyte Model of SCN5A-D1275N-Related Cardiac Sodium Channelopathy Reveals Diminished Sodium Currents Resulting From Enhanced Protein Degradation.
5. Yamamoto Y. CALM2-D134H Mutation Associated with Long-QT Syndrome Delayed Inactivation of L-type Ca2+ Currents in Human iPS Cells Derived Cardiomyocytes.
6. Nishiuchi S, Aiba T. Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers in Japan.
7. Kohjitani H. Novel Mathematical Models of All Subtypes of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
8. Hatani T, Funakoshi S, Thomas J. Deerinck, Eric A. Bushong, Takeshi Kimura, Shinya Yamanaka, Mark H. Ellisman, Masahiko Hoshijima, Yoshinori Yoshida. Imaging iPSC-derived Cardiomyocytes Engrafted in a Mouse Model of Myocardial Infarction Using Stably Expressed APEX2.
9. Hirose S. Modelling long-QT syndrome type 3 associated with near-miss sudden infant death syndrome using human-induced pluripotent stem cells.
10. Yimin W, Establishment of Homozygous LMNA Knockout Human Induced Pluripotent Stem Cells For Analyzing Disease-causing Mechanism of Laminopathies.
11. Takahama H, Takashio S, Hayashi T, Okatani-Nagai C, Nishikimi T, Nakagawa Y, Amaki M, Ohara T, Hasegawa T, Sugano Y, Kanzaki H, Yaduda S, Kangawa K, Minamino N, Anzai T. Impact of continuous reduction in B-type natriuretic peptide bioactivity during hospitalization in patients with advanced heart failure.
12. Takahama H, Takashio S, Hayashi T, Nishikimi T, Nakagawa Y, Amaki M, Hasegawa T, Sugano Y, Kanzaki H, Yaduda S, Kangawa K, Minamino N, Anzai T. Molar ratio of N-terminal fragment of pro-B-type natriuretic peptide(BNP) to proBNP predicts occurrence of acute kiney injury in patients with acute heart failure.

59th ASH Annual Meeting and Exposition December 9-12, Atlanta, USA

1. Morimoto Y, Chonabayashi K, Umeda M, Kawabata H, Takaori-Kondo A, Yoshida Y. Generation of patient-derived human induced pluripotent stem cells in X-linked sideroblastic anemia and novel therapeutic strategies.

Copyright(C) by Department of the circulatory organs,
Kyoto University Hospital. All Rights Reserved.